SHNXY Dividend: Shandong Xinhua Pharmaceutical Co Ltd Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

SHNXY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	8,494	8,466	8,100	7,502	6,560	6,005
Revenue Growth (YoY)	2%	5%	8%	14%	9%	7%
Cost of Revenue	6,805	6,476	5,772	5,509	4,819	4,238
Gross Profit	1,689	1,989	2,328	1,993	1,740	1,767
Selling, General & Admin	832	973	1,300	1,085	912	949
Research & Development	386	393	419	345	341	298
Operating Expenses	1,227	1,452	1,787	1,497	1,271	1,269
Other Non Operating Income (Expenses)	-1	4	2	-2	-2	-6
Pretax Income	446	533	532	471	421	411
Income Tax Expense	48	46	26	45	59	64
Net Income	382	470	496	411	348	324
Net Income Growth	-15%	-5%	21%	18%	7%	8%
Shares Outstanding (Diluted)	678.98	691.21	689.6	660.6	627.1	621.9
Shares Change (YoY)	-3%	0%	4%	5%	1%	0%
EPS (Diluted)	0.54	0.68	0.72	0.62	0.56	0.52
EPS Growth	-15%	-6%	16%	11%	8%	8%
Free Cash Flow	268	155	-59	513	9	140
Free Cash Flow Per Share	0.39	0.22	-0.08	0.77	0.01	0.22
Gross Margin	19.88%	23.49%	28.74%	26.56%	26.52%	29.42%
Operating Margin	5.42%	6.34%	6.66%	6.61%	7.14%	8.29%
Profit Margin	4.49%	5.55%	6.12%	5.47%	5.3%	5.39%
Free Cash Flow Margin	3.15%	1.83%	-0.72%	6.83%	0.13%	2.33%
EBITDA	--	677	631	588	541	552
EBITDA Margin	--	7.99%	7.79%	7.83%	8.24%	9.19%
D&A For EBITDA	--	140	91	92	72	54
EBIT	461	537	540	496	469	498
EBIT Margin	5.42%	6.34%	6.66%	6.61%	7.14%	8.29%
Effective Tax Rate	10.76%	8.63%	4.88%	9.55%	14.01%	15.57%